直肠系膜脂肪组织体积能否作为预测直肠癌新辅助放化疗反应的指标:一项基于CT的初步研究
本研究回顾性纳入88例局部晚期直肠癌患者,由两名放射科医生基于CT半定量测量腹部、皮下、内脏及直肠系膜脂肪体积,分析直肠系膜脂肪体积(MRV)与nCRT后病理反应的关系。无反应组平均MRV为69.6±31.0 ml,反应阳性组为105.8±47.5 ml(p<0.05);MRV≥69.4预测nCRT反应的敏感度为82.9%、特异度为58.5%,AUC为0.757(0.653-0.842),p<0.001。作者认为MRV可作为预测局部晚期直肠癌nCRT病理反应的新参数。
要点
- MRV≥69.4 ml预测nCRT病理反应的敏感度82.9%、特异度58.5%,AUC 0.757(0.653-0.842)。
- 反应阳性组MRV(105.8±47.5 ml)高于无反应组(69.6±31.0 ml),差异有统计学意义(p<0.05)。
- MRV与内脏脂肪体积相关性最高,且与N分期呈负相关。
核心结论
- 作者认为MRV可作为预测局部晚期直肠癌患者nCRT病理反应的新参数。
研究设计与样本
- 回顾性研究,纳入2017年1月至2020年6月诊断为局部晚期直肠癌的88例患者(平均年龄62.7岁,范围33-90岁;男31例、女57例)。
- 由两名放射科医生基于CT表现半定量测量腹部、皮下、内脏及直肠系膜脂肪组织成分。
- 按nCRT后有无病理反应分为两组;59例为3期病变,46例有淋巴结受累。
关键影像表现/征象
- 原文未报告影像征象。
诊断标准与关键数值
- 无反应组平均MRV为69.6±31.0 ml,反应阳性组为105.8±47.5 ml(p<0.05)。
- MRV与内脏脂肪体积相关性最高,MRV与N分期呈负相关。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study was to investigate the effect of mesorectal fat tissue volume (MRV) on the pathological response to neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer.
METHODS: 88 patients who had been diagnosed with locally advanced rectal cancer between January 2017 and June 2020 were reviewed retrospectively. The total abdominal, subcutaneous, visceral, and mesorectal fatty tissue components were measured semiquantitatively by two radiologists using computed tomography (CT)-based findings. The patients were divided into two groups as those with and without a pathological response to nCRT. The relationship of MRV with the other fat tissue components of the body was also evaluated.
RESULTS: We performed a retrospective analysis of 88 patients (mean age 62.7 years [range, 33-90 years]; 31 males and 57 females). A positive response to nCRT was present in 47 patients. There were 59 patients with stage 3 disease. 46 patients demonstrated lymph node involvement. The mean MRV was 69.6 ± 31.0 ml in no-response group and 105.8 ± 47.5 ml in response-positive patients (p < 0.05). MRV showed the highest correlation with visceral fat volume (VFV). There was a negative correlation between the MRV and the N stage. A cut-off value of ≥ 69.4 for MRV predicted the repsonse to nCRT, with 82.9% sensitivity and 58.5% specificity [AUC: 0.757 (0.653-0.842), p < 0.001] in receiver operating characteristic (ROC) curve analysis CONCLUSIONS: MRV can be used as a novel parameter in predicting of pathological response to nCRT in locally advanced rectal cancer patients.
引用
- Dilek O, Akkaya H, Parlatan C, et al. Can the mesorectal fat tissue volume be used as a predictive factor in foreseeing the response to neoadjuvant chemoradiotherapy in rectum cancer? A CT-based preliminary study. Abdom Radiol (NY). 2021. PMID: 33501511. doi:10.1007/s00261-021-02951-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。